Owlstone Medical enters collaboration agreement with Actelion to develop breath-based diagnostic test for pulmonary hypertension.
The Global Commission to End the Diagnostic Odyssey for Children has today published recommendations on how to solve the challenge of diagnosing rare diseases. The commission was set up by Takeda, Microsoft, and EURORDIS-Rare Diseases Europe to find solutions to core barriers preventing timely diagnosis for rare diseases.
A collaboration between Aether, the Californian bioprinter startup, and University College London (UCL) promises to develop a powerful new approach to 3D printing nanotechnology, while greatly reducing the cost compared with competitor offerings.
Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for some of the most debilitating degenerative diseases.